COMP <GO>
MO vs ABBV // RETURN ON INVESTED CAPITAL (ROIC)
Altria Group Inc. (NYSE) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: MO 8
— ABBV 7
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: MO
LAST: $78.03 (+1.67%) • MKT CAP: $128.15B
roic
48.40%
LAST: $294.89 (+1.41%) • MKT CAP: $513.86B
roic
29.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MO VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MO | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 62.50% | 70.20% | -7.70 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 48.40% | 29.00% | +19.40 | MO | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.7x | 33.3x | -18.60 | MO | /valuation <GO> |
| Free Cash Flow Yield | 7.08% | 3.47% | +3.61 | MO | /fcf-yield <GO> |
| Operating Margin | 42.50% | 24.60% | +17.90 | MO | /operating-margins <GO> |
| Net Profit Margin | 29.80% | 6.90% | +22.90 | MO | /net-margins <GO> |
| Revenue Growth (YoY) | -3.10% | 8.60% | -11.70 | ABBV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 5.43% | 2.27% | +3.16 | MO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.90 | 5.33 | -0.43 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | ABBV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 7.40% | -0.80 | MO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 69.7 | 72.8 | -3.06 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.92 | 1.15 | -0.23 | ABBV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 17.1x | 113.1x | -96.00 | MO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $128.15B | $513.86B | -$385.71B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MO REV | ABBV REV | MO GROSS % | ABBV GROSS % | MO FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $23.28B | $61.16B | 62.5% | 70.2% | $9.07B | $17.82B |
| FY 2024 | $24.02B | $56.33B | 59.8% | 70.0% | $8.61B | $17.83B |
| FY 2023 | $24.48B | $54.32B | 44.0% | 44.0% | $8.19B | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MO // BETA 0.92
ABBV // BETA 1.15